Efficacy and safety of single-dose mizoribine for patients with rheumatoid arthritis: results at 6 months after switching from a multiple-dose regimen without a change in total daily dose

Author: Nishimura Keita  

Publisher: Springer Publishing Company

ISSN: 1439-7595

Source: Modern Rheumatology, Vol.21, Iss.2, 2011-04, pp. : 158-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content